In brief
A National Cancer Institute R01 proposal for a 200-caregiver trial of Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C) versus supportive psychotherapy; an earlier pilot found it feasible and helpful, but the larger efficacy question is still open.
What this article is about
Quick Answer
A National Cancer Institute R01 proposal for a 200-caregiver trial of Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C) versus supportive psychotherapy; an earlier pilot found it feasible and helpful, but the larger efficacy question is still open.
Student takeaways
Key Takeaways
- The record is a National Cancer Institute R01 proposal that also reports results from a completed pilot randomized controlled trial of Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C).
- According to the abstract, the pilot found MCP-C feasible and acceptable and superior to the comparison in improving meaning, benefit-finding, depression, and spiritual well-being (pilot-level findings, not definitive efficacy).
- The proposed larger trial would randomize 200 caregivers of patients with advanced (Stage III/IV solid tumor) cancer to 7 sessions of MCP-C or to Supportive Psychotherapy for Caregivers, the standard community comparison.
- Primary outcomes are meaning and spiritual well-being; secondary outcomes include anxiety, depression, benefit-finding, caregiver burden, and social support, assessed at baseline, post-treatment, and 6- and 12-month follow-up, with bereavement outcomes also tracked.
- The team predicts MCP-C will yield greater improvements and that sense of meaning will mediate treatment effects; these are stated hypotheses for the proposed trial, not established results.
Student summary
Why This Research Matters
This record is a funded research proposal (an R01 grant from the National Cancer Institute) that also refers back to results from an earlier pilot study. Understanding the difference is important. The larger trial described here has not happened yet, so its outcomes are predictions and aims, not findings. However, the abstract does report that a smaller pilot randomized controlled trial was already completed, and those pilot results can be described as findings, as long as we remember that pilots are small and meant mainly to test whether a bigger study is workable.
The project centers on family caregivers of people with advanced cancer. A caregiver here means a partner, relative, or friend who provides physical and emotional support to a patient with a serious, often life-limiting illness. The abstract notes that in 2020 an estimated 53 million people in the United States served as family caregivers, and that caregivers increasingly take on tasks once handled by health professionals, including serving as healthcare proxies and helping with communication and advance care planning. This work is described as heavy, and much of its burden is tied to existential distress, meaning the deep worry and searching that arise when facing mortality, loss, and questions of meaning. The abstract links this distress to anxiety, depression, poor quality of life, and difficult grief in bereavement. At the same time, it points out that caregiving can bring a profound sense of meaning and purpose, and that helping caregivers address existential distress can improve their well-being even amid hardship.
The intervention being studied is Meaning-Centered Psychotherapy adapted for cancer caregivers, abbreviated MCP-C. The parent approach, Meaning-Centered Psychotherapy, was developed to reduce existential distress and enhance well-being in patients with advanced cancer, and the team adapted it into a structured, manualized program for caregivers. According to the abstract, the completed pilot randomized controlled trial found that MCP-C was feasible and acceptable, and that it outperformed the comparison in improving meaning, benefit-finding, depression, and spiritual well-being. These are encouraging early signals, but pilots are not designed to give definitive answers.
The proposed larger trial would test MCP-C more rigorously. The plan is to enroll 200 caregivers of patients with advanced (Stage III or IV solid tumor) cancer and randomly assign them either to 7 sessions of MCP-C or to Supportive Psychotherapy for Caregivers, described as the standard of community-based caregiver care. Meaning and spiritual well-being are the primary outcomes, while anxiety, depression, benefit-finding, caregiver burden, and social support are secondary outcomes. Assessments would occur at baseline, right after treatment, and at 6 and 12 months. The team also plans to measure bereavement outcomes, including grief before and after loss, preparedness for loss, and regret. The researchers predict that MCP-C will produce greater improvements and that a person's sense of meaning will help explain, or mediate, the treatment's effects. These are hypotheses, not results.
For a nursing student, several appraisal points stand out. First, notice the layered evidence: a completed pilot supports feasibility and early benefit, while the main efficacy question is still open. It would be inaccurate to say MCP-C is proven to reduce caregiver depression based on a pilot alone. Second, the use of an active comparison, supportive psychotherapy rather than no treatment, is a strength, because it tests whether the specific meaning-centered approach adds value beyond general support. Third, the long follow-up and inclusion of bereavement outcomes reflect the reality that caregiving and grief extend well beyond a patient's death.
Clinically, the work reinforces that caregivers are a vulnerable group whose needs are part of good palliative and family-centered care. Nurses can validate caregivers' distress, screen for anxiety and depression, connect families to psychological and spiritual support, and recognize meaning-making as a genuine source of resilience. A gentle caution: existential and spiritual distress are sensitive areas, and support should follow the caregiver's own beliefs and pace rather than imposing a particular worldview. Nurses should also know their scope, referring to trained mental health professionals for structured therapies like MCP-C while providing compassionate presence and practical support themselves.
Source abstract
Study Overview
PROJECT SUMMARY In 2020, 53 million people in the U.S. served as family caregivers, the partners, relatives, and friends who provide assistance (i.e., physical, emotional) to patients with often life-threatening, incurable illnesses. Caregivers are increasingly tasked with responsibilities once performed by medical professionals, and the availability and health of supportive caregivers is more critical than ever. A growing number of caregivers provide care to patients with advanced, life-limiting cancers, and are tasked with critical patient care responsibilities, and play a significant role in healthcare communication and advanced care planning as healthcare proxies. The burden of these responsibilities is great and is driven largely by existential distress, which contributes to anxiety, depression, poor quality of life, and mental health challenges in bereavement. Concurrently, caregiving is an opportunity to experience a profound sense of meaning and purpose; caregiving allows for the realization of new strengths and capacities, healing of relationships, and refinement of life goals. When existential distress is addressed, caregivers can experience an enhanced sense of well-being despite their challenges. While many interventions have been developed to support cancer caregivers, none directly target existential distress. Our group adapted Meaning-Centered Psychotherapy (MCP), a highly effective intervention in decreasing existential distress and enhancing well-being among patients with advanced cancer, for cancer caregivers. Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C) is a stakeholder- informed, innovative, manualized intervention designed to assist caregivers to connect to meaning and purpose in life, despite the challenges of caregiving. Results of our pilot randomized controlled demonstrated MCP-C’s feasibility, acceptability, and superiority in improving meaning, benefit-finding, depression, and spiritual wellbeing. In the proposed trial, we will more rigorously evaluate the efficacy of MCP-C through a randomized controlled trial of 200 caregivers of patients with advanced (Stage III/IV solid tumor) cancer who will receive 7 sessions of MCP-C or Supportive Psychotherapy for Caregivers (SP-C), the standard of community-based caregiver care. Participants will undergo assessments of meaning and spiritual wellbeing (primary outcomes), and anxiety, depression, benefit finding, caregiver burden, and social support (secondary outcomes) at baseline, post-treatment, and at 6- and 12-months follow-up. Bereavement outcomes including pre- and post-loss grief, preparedness for loss, and regret will also be evaluated at each time point. We predict MCP-C will result in greater improvements in primary and secondary outcomes, and that sense of meaning in life will mediate treatment effects. We also predict that MCP-C will result in better preparedness for loss and improved pre- and post-loss grief and regret. Our results will enhance our capacity to powerfully target existential distress in caregivers of patients with advance cancer and by extension, improve their capacity to provide critical care to patients at end-of-life.
Evidence appraisal
Main Findings
- The record is a National Cancer Institute R01 proposal that also reports results from a completed pilot randomized controlled trial of Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C).
- According to the abstract, the pilot found MCP-C feasible and acceptable and superior to the comparison in improving meaning, benefit-finding, depression, and spiritual well-being (pilot-level findings, not definitive efficacy).
- The proposed larger trial would randomize 200 caregivers of patients with advanced (Stage III/IV solid tumor) cancer to 7 sessions of MCP-C or to Supportive Psychotherapy for Caregivers, the standard community comparison.
- Primary outcomes are meaning and spiritual well-being; secondary outcomes include anxiety, depression, benefit-finding, caregiver burden, and social support, assessed at baseline, post-treatment, and 6- and 12-month follow-up, with bereavement outcomes also tracked.
- The team predicts MCP-C will yield greater improvements and that sense of meaning will mediate treatment effects; these are stated hypotheses for the proposed trial, not established results.
Practice transfer
Clinical Relevance
- Nurses should recognize family caregivers of patients with advanced cancer as a vulnerable group whose emotional and existential needs are part of good palliative and family-centered care.
- Screening caregivers for anxiety, depression, and distress, and connecting them to psychological and spiritual support, is a concrete way to reduce caregiver burden.
- Meaning-making can be a genuine source of resilience for caregivers, so nurses can validate and support caregivers' search for purpose without minimizing their hardship.
- Existential and spiritual support must follow the caregiver's own beliefs, culture, and pace; nurses should offer presence and options rather than imposing a particular worldview.
- Structured therapies such as MCP-C are delivered by trained mental health professionals, so nurses should provide compassionate support and timely referral within their scope of practice.
Faculty notes
Educational Relevance
This National Cancer Institute R01 proposal is a rich teaching case because it layers evidence: it reports a completed pilot randomized controlled trial and proposes a larger efficacy trial. Use it to help students separate what is already shown (pilot feasibility, acceptability, and superiority over comparison in improving meaning, benefit-finding, depression, and spiritual well-being) from what is merely predicted (efficacy in the planned 200-caregiver trial). The intervention, Meaning-Centered Psychotherapy for Cancer Caregivers (MCP-C), is compared against an active control, Supportive Psychotherapy for Caregivers, which is a strong prompt for discussing why active comparators strengthen inference. The design also illustrates primary versus secondary outcomes (meaning and spiritual well-being as primary; anxiety, depression, benefit-finding, burden, and social support as secondary), long-term and bereavement follow-up (baseline, post-treatment, 6 and 12 months), and the concept of mediation (meaning as a proposed mechanism). Thematically, it centers caregiver burden, existential distress, and palliative and family-centered care. Emphasize sensitivity: existential and spiritual distress must be approached within the caregiver's own belief framework, and structured psychotherapy belongs to trained mental health clinicians, while nurses provide screening, validation, referral, and compassionate presence.
Critical appraisal
Limitations
- The main efficacy trial is a proposal, so its predicted benefits (superiority of MCP-C, meaning as a mediator) are hypotheses, not results.
- The supporting evidence to date comes from a pilot randomized controlled trial, which by design is small and intended to establish feasibility rather than prove efficacy.
- Findings would apply to caregivers of patients with advanced solid-tumor cancer and may not generalize to other illnesses, caregiving contexts, or cultural settings.
Classroom use
Discussion Questions
- Why is it important to distinguish the completed pilot results from the predicted outcomes of the larger proposed trial?
- What is existential distress, and why might caregivers of patients with advanced cancer be especially prone to it?
- How can caregiving be a source of both heavy burden and profound meaning at the same time?
- Why is using an active comparison (supportive psychotherapy) a stronger design than comparing MCP-C to no treatment?
- What is the difference between primary and secondary outcomes, and how would you identify them in this study?
- Why does the study measure outcomes at 6 and 12 months and include bereavement outcomes such as grief and regret?
- What does it mean for 'sense of meaning' to mediate the treatment's effects, and why would researchers want to test that?
- How can a nurse support a caregiver's search for meaning without imposing the nurse's own beliefs?
- Where is the boundary between the compassionate support a nurse provides and the structured psychotherapy delivered by a mental health professional?
- How might a nurse screen a caregiver for depression and distress during a patient's cancer treatment?
Search-ready answers
Frequently asked questions
Is MCP-C proven to reduce caregiver depression?
A completed pilot suggested benefit, but the larger efficacy trial is still proposed. Pilot results are promising, not definitive proof.
What is Meaning-Centered Psychotherapy?
A structured therapy developed to reduce existential distress and enhance well-being; here it is adapted for cancer caregivers as MCP-C.
Who would take part in the proposed trial?
200 family caregivers of patients with advanced (Stage III/IV solid tumor) cancer.
What is being compared?
7 sessions of MCP-C versus Supportive Psychotherapy for Caregivers, the standard community-based caregiver care.
What outcomes matter most in the study?
Meaning and spiritual well-being are primary; anxiety, depression, benefit-finding, caregiver burden, and social support are secondary.
Why does the study follow caregivers for a year and into bereavement?
Because caregiving and grief extend well beyond the patient's death, so lasting effects and bereavement outcomes matter.
Can caregiving be positive as well as burdensome?
Yes. The abstract notes caregiving can bring meaning, purpose, new strengths, and healing of relationships alongside its burdens.
What can a nurse do to help a struggling caregiver?
Recognize their needs, screen for depression and distress, validate their experience, and connect them to mental health and spiritual support.
Should a nurse deliver MCP-C themselves?
No, unless trained and qualified. Structured psychotherapy is provided by trained clinicians; nurses offer support and referral within scope.
How should existential or spiritual support be approached?
Sensitively and within the caregiver's own beliefs and pace, never by imposing a particular worldview.